Clinical Trial

Safety Evaluation of Pueraria Lobata Radix in Specific Consumption Scenarios for Type 2 Diabetes

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This real-world study aims to investigate the association between the consumption of Pueraria lobata radix and adverse events in patients with type 2 diabetes mellitus (T2DM) under special scenarios. By retrospectively analyzing the clinical data of patients with T2DM, we will evaluate the safety profile of Pueraria lobata radix in different special populations, identify potential risk factors, and provide evidence-based support for the safe consumption and clinical use of Pueraria lobata radix.
Trial Details
NCT Number NCT07079085
Lead Sponsor Jiangxi University of Traditional Chinese Medicine
Collaborators: The Affiliated Hospital of Jiangxi University of Traditional Chinese Medicine
Conditions Type 2 Diabetes
Enrollment 500 participants
Start Date 2025-08-01
Primary Completion 2026-12-30 (estimated)
Study Completion 2026-12-30 (estimated)
Updated on ClinicalTrials.gov 2025-07-22